For the development of the new biomarkers using the technique of Mass-spectrometry 7,5 ml EDTA blood and a dry blood spot filter card are taken. To proof the correct Alport diagnosis in those patients where up to the enrollment in the study no genetic testing has been done, sequencing of Alport disease will be done.